Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...
OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...
Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...
Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...
UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...
Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...
TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...
Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...
Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...
A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...
CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...
